vimarsana.com
Home
Live Updates
Inhibikase Therapeutics to Present at the 11th Annual Alzheimers & Parkinsons Drug Development Summit : comparemela.com
Inhibikase Therapeutics to Present at the 11th Annual Alzheimer's & Parkinson's Drug Development Summit
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase...
Related Keywords
Boston ,
Massachusetts ,
United States ,
California ,
Georgia ,
Atlanta ,
San Francisco ,
Miltonh Werner ,
Alex Lobo ,
Milton Werner ,
Linkedin ,
Alzheimer Parkinson Drug Development Summit ,
Inhibikase Therapeutics Inc ,
Twitter ,
Company Contact ,
Nasdaq ,
Exchange Commission ,
Inhibikase Or Company ,
Prnewswire Inhibikase Therapeutics Inc ,
Youtube ,
Facebook ,
Sternir Inc ,
Abelson Tyrosine Kinases ,
Chief Executive Officer ,
Annual Alzheimer ,
Drug Development ,
Small Molecule ,
Abl Kinase Inhibitor ,
Potential Disease Modifying Therapy ,
Clinical Developments ,
Disease Research Date ,
Hyatt Centric Fisherman ,
Wharf San ,
Abelson Tyrosine Kinase ,
Ableson Tyrosine ,
Multiple System Atrophy ,
Private Securities Litigation Reform Act ,
Inhibikase Therapeutics ,
Nc ,
comparemela.com © 2020. All Rights Reserved.